Placeholder canvas

Option 01

Senior Leadership

R & D

Commercial

Navin-team.005

Rajendra Kumar
Sahu

Chief Executive
Officer

people_blank

Jordi
Robinson

Chief Commercial
Officer

raghavendar

Dr Raghavendar
Rao Morthala

Head,
R&D

Navin-team.001

Ajay
Ohri

Head,
BD US

Matthew-Stent.001

Dr Matthew
Stent

Head, BD Europe
& Key Accounts

Option 02

Senior Leadership

Navin-team.005

Rajendra Kumar Sahu

Chief Executive Officer

Rajendra has over 26 years of rich experience working with large generic pharmaceutical companies like Dr Reddys, Glenmark, Ranbaxy and Sun Pharmaceutical handling a diverse set of roles spanning across projects, process engineering, technology transfer, production and business development.

Rajendra holds a Bachelor’s degree in Chemical Engineering from NIT, Rourkela and has done Strategic management program from IIM, Ahmedabad. He is working with Navin Fluorine since Apr’ 2020.

people_blank

Jordi Robinson

Chief Commercial Officer

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged.

R & D

raghavendar

Dr Raghavendar Rao Morthala

Head, R&D

Raghavendar Rao heads Process and Analytical R&D at Navin Molecular. He has more than 20 years’ experience in Healthcare and Pharma Industries, specifically CDMO and API generics. He is a synthetic organic chemist by training, with a PhD and Post-Doc from the University of Strathclyde, Glasgow, UK. His previous experience includes stints at Syngene International, Piramal Pharma Solutions, Sai Life Sciences, Dr Reddy’s and Government of Andhra Pradesh.

Commercial

Navin-team.001

Ajay Ohri

Head, BD US

Ajay is a senior executive in the biopharma and chemical space with over 30 years’ of experience. His industry prowess from holding global positions, managing business development teams and operations that have propagated strong international relationships. It has enabled him to build unique business strategies with a customer centric focus driving R&D initiatives, establishing brands & commercial supply management in the biopharma and chemical space.

Matthew-Stent.001

Dr Matthew Stent

Head, BD Europe & Key Accounts

Matthew heads-up our European business development team and is responsible for strategic key accounts. He joined Navin in 2015 and set up the project management function, building an international team to manage both pre-sales (RFP evaluation and quoting) and project delivery coordination (technical oversight and customer communication), and transitioned into his current commercial role in early 2023. Matthew is a synthetic organic chemist by training: he has a DPhil from the University of Oxford, UK, completed a Post-Doc at the University of Texas, USA, and has more than 15 years’ experience in techno-commercial roles in customer facing positions.

Option 03

Senior Leadership

Matthew-Stent.001

Dr Matthew Stent

Head, BD Europe & Key Accounts

Matthew heads-up our European business development team and is responsible for strategic key accounts. He joined Navin in 2015 and set up the project management function, building an international team to manage both pre-sales (RFP evaluation and quoting) and project delivery coordination (technical oversight and customer communication), and transitioned into his current commercial role in early 2023. Matthew is a synthetic organic chemist by training: he has a DPhil from the University of Oxford, UK, completed a Post-Doc at the University of Texas, USA, and has more than 15 years’ experience in techno-commercial roles in customer facing positions.

Navin-team.001

Ajay Ohri

Head, BD US

Ajay is a senior executive in the biopharma and chemical space with over 30 years’ of experience. His industry prowess from holding global positions, managing business development teams and operations that have propagated strong international relationships. It has enabled him to build unique business strategies with a customer centric focus driving R&D initiatives, establishing brands & commercial supply management in the biopharma and chemical space.

Rajendra Kumar Sahu

Chief Executive Officer

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged.

Jordi Robinson

Chief Commercial Officer

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged.

Dr Raghavendar Rao Morthala

Head, R&D

Raghavendar Rao heads Process and Analytical R&D at Navin Molecular. He has more than 20 years’ experience in Healthcare and Pharma Industries, specifically CDMO and API generics. He is a synthetic organic chemist by training, with a PhD and Post-Doc from the University of Strathclyde, Glasgow, UK. His previous experience includes stints at Syngene International, Piramal Pharma Solutions, Sai Life Sciences, Dr Reddy’s and Government of Andhra Pradesh.

Ajay Ohri

Head, BD US

Ajay is a senior executive in the biopharma and chemical space with over 30 years’ of experience. His industry prowess from holding global positions, managing business development teams and operations that have propagated strong international relationships. It has enabled him to build unique business strategies with a customer centric focus driving R&D initiatives, establishing brands & commercial supply management in the biopharma and chemical space.

Dr Matthew Stent

Head, BD Europe & Key Accounts Matthew heads-up our European business development team and is responsible for strategic key accounts. He joined Navin in 2015 and set up the project management function, building an international team to manage both pre-sales (RFP evaluation and quoting) and project delivery coordination (technical oversight and customer communication), and transitioned into his current commercial role in early 2023. Matthew is a synthetic organic chemist by training: he has a DPhil from the University of Oxford, UK, completed a Post-Doc at the University of Texas, USA, and has more than 15 years’ experience in techno-commercial roles in customer facing positions.

Option 04

Senior Leadership

[sp_easyaccordion id="8498"]

R & D

[sp_easyaccordion id="8514"]

Commercial

[sp_easyaccordion id="8521"]